On April 23, 2025, AMIA joined over 100 organizations urging Congress to allocate at least $1.7 billion for the Advanced Research Projects Agency for Health (ARPA-H) in FY 2026, emphasizing the importance of maintaining its independence within the Department of Health and Human Services. ARPA-H, modeled after DARPA, has initiated […]
AMIA raised concerns about the evidence behind the HHS reorganization decisions and questions the exclusion of the Assistant Secretary for Technology Policy/Office of the National Coordinator of Health IT (ASTP). It highlights the importance of ASTP in securing patient data and supporting clinical care. AMIA also questioned the potential move […]
AMIA responded to the FDA's draft guidance on "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations." We commended the FDA for its comprehensive approach to ensuring the safe and effective use of AI-enabled devices in healthcare. The comment letter emphasized the importance of transparency, bias control, and […]
